Abstract

This commentary summarizes the results and clinical implications of validation studies evaluating the performance of the 2023 Duke-ISCID criteria for infective endocarditis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Acute and subacute bacterial endocarditis.
Morton Hamburger
Archives of internal medicine | VOL. 112
Morton HamburgerMorton Hamburger
01 Jul 1963
ANTIMICROBIAL ACTIVITY OF DALBAVANCIN AGAINST GRAM-POSITIVE BACTERIA ISOLATED FROM PATIENTS WITH INFECTIVE ENDOCARDITIS FROM THE UNITED STATES AND EUROPE (2016-2020): RESULTS FROM THE INTERNATIONAL DALBAVANCIN EVALUATION OF ACTIVITY (IDEA) PROGRAM
RODRIGO MENDES ... CECILIA CARVALHAES
Chest | VOL. 160
RODRIGO MENDES, et. al.RODRIGO MENDES ... CECILIA CARVALHAES
01 Oct 2021
ANTIMICROBIAL ACTIVITY OF CEFTAROLINE AGAINST STAPHYLOCOCCUS AUREUS ISOLATED FROM PATIENTS WITH INFECTIVE ENDOCARDITIS WORLDWIDE (2010-2019)
Cecilia Carvalhaes ... Rodrigo Mendes
Chest | VOL. 158
Cecilia Carvalhaes, et. al.Cecilia Carvalhaes ... Rodrigo Mendes
01 Oct 2020
Infective endocarditis in children and adolescents: a different profile with clinical implications.
Daniel de Castro Campos ... M. Carmen Fariñas
Pediatric research | VOL. 92
Daniel de Castro Campos, et. al.Daniel de Castro Campos ... M. Carmen Fariñas
11 Feb 2022
View more papers

More From: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Paper Title
Journal
Date
Author
The Role of Value-Based Healthcare in enhancing Antimicrobial Stewardship for End-of-Life Patients.
Marcelo Carneiro ...
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | VOL. -
Marcelo Carneiro, et. al.Marcelo Carneiro ...
16 Apr 2024
Correction to: Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients.
-
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | VOL. -
--
15 Apr 2024
Which form of tenofovir should be used worldwide: TDF or TAF?
Andrew Hill
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | VOL. -
Andrew HillAndrew Hill
12 Apr 2024
Antiretrovirals and Weight Change: Weighing the Evidence.
David Alain Wohl ... Calvin Cohen
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | VOL. -
David Alain Wohl, et. al.David Alain Wohl ... Calvin Cohen
12 Apr 2024
View more papers